The mechanisms which effect alterations in the secretion of aldosterone by the adrenal cortex may be nervous, humoral or both. The present study was undertaken to examine the possibility that a humoral agent stimulates the adrenal cortex to secrete aldosterone in dogs with experimental secondary hyperaldosteronism produced by constriction of the thoracic inferior vena cava. These animals secrete large amounts of aldosterone (1) and show almost complete retention of Na (2). To test the hypothesis of a humoral mechanism, the effect on aldosterone secretion was studied in normal recipient animals or in the isolated adrenals of normal dogs during cross-circulation of blood from dogs with constriction of the thoracic inferior vena cava. Corticosterone secretion was also measured to evaluate the possible role of adrenocorticotropic hormone (ACTH) in the aldosterone regulatory system.
The mechanisms which effect alterations in the secretion of aldosterone by the adrenal cortex may be nervous, humoral or both. The present study was undertaken to examine the possibility that a humoral agent stimulates the adrenal cortex to secrete aldosterone in dogs with experimental secondary hyperaldosteronism produced by constriction of the thoracic inferior vena cava. These animals secrete large amounts of aldosterone (1) and show almost complete retention of Na (2) . To test the hypothesis of a humoral mechanism, the effect on aldosterone secretion was studied in normal recipient animals or in the isolated adrenals of normal dogs during cross-circulation of blood from dogs with constriction of the thoracic inferior vena cava. Corticosterone secretion was also measured to evaluate the possible role of adrenocorticotropic hormone (ACTH) in the aldosterone regulatory system.
METHODS
The basic plan of the experiments consisted of crosscirculation of blood from a donor into a recipient animal or into the isolated adrenal glands of a recipient animal. Secondary hyperaldosteronism was produced in the donor animals by either acute or chronic constriction of the thoracic inferior vena cava. Acute caval constriction was performed on normal dogs. In the chronic donor dogs, ascites had been present for one to three weeks, and Na excretion on the day before the experiment was less than 4 mEq. per day; Na and K intakes were 60 and 18 mEq. per day, respectively. Also, aldosterone secretion from the right adrenal gland was measured in a group of eight dogs with chronic thoracic inferior vena cava constriction to determine the magnitude and consistency of hypersecretion. All animals were mongrel dogs which weighed 15 to 20 Kg. Nembutal® anesthesia was used.
Each dog received 15,000 I.U. of heparin before collection of adrenal vein blood and before cross-circulation. * A preliminary report was given at the Laurentian Hormone Conference, September, 1958.
Two types of experiments were performed. In the first group of experiments (three pairs of dogs), crosscirculation was achieved through the femoral vessels by polyethylene tubing (i.d., 3.5 mm.). Exchange of blood was regulated by screw clamps so that arterial and venous pressures remained similar to the values recorded before cross-circulation. Adrenal vein blood was collected from both animals from the right adrenal gland by cannulation of the right adrenolumbar vein as described previously (1) . In the first pair of dogs, crosscirculation was performed between two normal animals.
After control determinations in both animals, the thoracic inferior vena cava was constricted in one of the dogs which became the donor. In the two other experiments of this group, dogs with chronic thoracic caval constriction were the donor animals. Under these circumstances, control observations were made in both the chronic donor and the normal recipient before crosscirculation was established.
In the second group of experiments (15 pairs of dogs), blood was circulated from a donor animal with chronic thoracic caval constriction and ascites or from a normal dog into the isolated adrenals of a normal recipient animal ( Figure 1 ). Cross-circulation of blood from normal dogs provided a control on the effect of cross-circulation per se. The recipient's adrenals were isolated in situ with segments of aorta and inferior vena cava by the procedure of Hilton and co-workers (3) . Care was taken to include in the arterial circulation to the lower pole of the right adrenal gland a small artery arising from the aorta. Polyethylene tubing was used for all connections. During the control and recovery periods, blood was circulated from the recipient's carotid artery (autoperfusion) into the isolated aorta, through the adrenal glands, into the inferior vena cava and, subsequently, into the systemic circulation of the recipient by way of the external jugular vein. During the period of cross-circulation, blood perfused the isolated adrenals of the recipient from the femoral artery of the donor and returned to the donor's femoral vein. An infusion of norepinephrine (100 ,ug. per ml.) was given in some instances (Tables I and II) during the latter part of the experiment to support arterial pressure and adrenal blood flow.
Collections of 10 ml. of adrenal vein blood and 10 ml. monoacetate-C1' in 0.1 ml. of ethanol were added to each sample to correct for losses of aldosterone and corticosterone during all subsequent chromatographies. The exact number of cpm for each steroid in 0.1 ml. of ethanol was determined when the labeled steroids from the plasma samples were counted. Distilled water (0.8 ml.) was added to each tube, extraction was carried out with about 5 ml. of dichloromethane and the dichloromethane extract was washed once with 1 ml. of distilled water. The dichloromethane was dried under a stream of air at 37°. Adrenosterone (0.02 ml.) and corticosterone monoacetate (0.02 ml.) in concentrations of 1 mg. per ml. in absolute ethanol were added to each sample to provide a visible marker in ultraviolet light for aldosterone and enough corticosterone monoacetate for it to be visible. 10 drops of dichloromethane and chromatographed in a cyclohexane (100 parts), benzene (40 parts), methanol (100 parts) and water (20 parts) system by descending chromatography. After a minimal period of 45 minutes for equilibration, the chromatogram was developed at room temperature (750 F.) for 16 to 18 hours by adding 90 ml. of the mobile phase. The paper was scanned with ultraviolet light, each spot of corticosterone monoacetate and adrenosterone was marked and areas of paper containing corticosterone monoacetate and aldosterone diacetate were cut out. The relation of adrenosterone to aldosterone diacetate had been previously ascertained by locating the position of aldosterone diacetate-C'4 with a strip counter and the visible spot of adrenosterone by ultraviolet light. This relationship was checked periodically. The samples of corticosterone monoacetate and aldosterone diacetate were eluted into separate tubes with 10 ml. of absolute methanol. Both samples were dried.
For aldosterone, the second chromatography was carried out with a cyclohexane (100 parts), dioxane (100 parts), methanol (50 parts) and water (25 parts) system. The reference marker for aldosterone diacetate in this chromatographic system was 11-keto, 17ahydroxypro-gesterone (0.02 ml. of a 1 mg. per ml. solution); the exact relation of the mobility of this steroid and aldosterone had been determined previously. The chromatogram was developed for 14 to 16 hours, the aldosterone diacetate was eluted with methanol and the sample was dried under air. To alter the mobility of the steroid and to insure better purification, each sample was treated with 0.1 ml. of 0.5 per cent chromic trioxide in glacial acetic acid. The tube was rotated to allow the chromate solution to wet the residue and allowed to stand for 10 minutes.
The reaction was stopped with 2 ml. of 20 per cent absolute ethanol in water. Approximately 10 ml. of dichloromethane was added and each tube was shaken vigorously; the aqueous layer was aspirated and discarded. Each sample was washed twice with 1 ml. of distilled water and the dichloromethane was dried under an air stream. The third chromatography for the oxidation product of aldosterone diacetate was performed in a cyclohexane (100 parts), benzene (50 parts), methanol (100 parts) and water (25 parts) system. The reference marker was 0.02 ml. of a 1 mg. per ml. solution of llcahydroxyprogesterone. The chromatogram was developed for 24 to 26 hours. Each sample of the oxidation product of aldosterone diacetate was eluted into a counting vial and dried under an air stream. To each vial, 5 A second chromatography for corticosterone monoacetate was performed with a cyclohexane (100 parts), dioxane (100 parts), methanol (50 parts) and water (25 parts) system. The chromatogram was developed for 12 to 15 hours. The corticosterone was eluted into counting vials, dried and the phosphor solution added.
The samples of aldosterone and of corticosterone were counted to determine the tritium and carbon-14 radioactivity in a liquid scintillation spectrometer (Packard Tri-Carb Scintillation Spectrometer). Each sample was counted at a voltage of 890 (discriminator setting of 10 to 50) to determine the radioactivity of carbon-14 and at 1,270 volts (discriminator setting of 10-00) to obtain the combined activity of carbon-14 and tritium. The number of tritium counts at 1,270 volts was obtained by subtracting the contribution of carbon-14 at this voltage from the total counts; the counts of carbon-14 at the high voltage were calculated from the ratio of pure carbon-14 counts at 1,270 volts to carbon-14 counts at 890 volts.
The quantity of aldosterone or corticosterone in a sample was calculated from the yield of tritium radioactivity, the amount of carbon-14 lost during chromatography and the specific activity of the tritium-labeled acetic anhydride.
The specific activity of the tritium-labeled acetic anhydride was determined by acetylating hydrocortisone and determining the specific activity of the acetylated steroid. Dry hydrocortisone (0.5 mg.) was acetylated for 20 hours at room temperature with 0.02 ml. of tritium-labeled acetic anhydride in the presence of 0.02 ml. of anhydrous pyridine. After acetylation, 1 ml. of 20 per cent ethanol in water was added to the reaction mixture. The hydrocortisone acetate was extracted from the ethanol solution with five volumes of dichloromethane. The dichloromethane was washed with 1 ml. of distilled water and dried under an air stream. The sample of hydrocor- (Table III) ; assays were carried out at each level and on the same pool of adrenal vein plasma with no added aldosterone. The H'/C1" ratio was determined after each of the three chromatographies by determining tritium and carbon counts from an aliquot of the eluate at the 1,270 voltage setting. The solvent systems and time for development of the chromatograms were the same as those described previously for aldosterone. The ratio of H'/C1' was essentially the same after the second and third chromatographies (Table III) . This finding indicates that no tritium-labeled impurities were present after the second chromatography. Nevertheless, a third chromatography has been used in all routine studies. Recovery data on the same plasma samples are presented in Table III. A similar study of the specificity of this technique for corticosterone was made. The first two chromatographies were the same as those used for corticosterone in routine 5.96s * Three ml. of the same pool of adrenal vein plasma from the isolated adrenals of a normal dog were used for each sample. No aldosterone was added to Sample N. The concentration of the aldosterone added was determined by measuring a stock solution in the ultraviolet at 242 m,u (e = 15,850). The higher values given represent added aldosterone calculated on this basis. The lower values were calculated from data obtained by double isotope derivative analysis of the same stock solution of aldosterone after addition to plasma (see Table IV The data that were obtained are compared (Figure 2) with those reported previously (5) for normal dogs. Aldosterone secretion was elevated in every animal with caval constriction and the mean rate of aldosterone secretion of 0.146 ,Lg. per minute for dogs with caval constriction was sixfold greater than the average rate of 0.024 ug. per minute for normal dogs (t = 5.8; p < 0.001 ).
It was concluded that the consistency and magnitude of the hyperaldosteronism was sufficient to justify performance of cross-circulation without measurements of aldosterone secretion in the chronic donor dogs.
Seven cross-circulation experiments were conducted using dogs with chronic thoracic caval constriction as donors (Table I ). After three control determinations during autoperfusion of the recipient's isolated adrenals, cross-circulation was established with a dog with chronic thoracic caval constriction. In five of the seven experiments, a recovery period with autoperfusion was obtained.
Aldosterone secretion increased in every instance (average increase was 129 per cent) and returned to the control level during the recovery periods (Table I, Figure 3) . A statistical analysis of variance showed that the increase was significant at the 1 per cent level (F = 14.50, t = 3.80). The increase in aldosterone secretion was associated with a greater increase percentage-wise (196 per cent) in the concentration of aldosterone in adrenal vein plasma. Since blood from the donor dogs perfused isolated adrenal glands, the data show a direct effect upon the recipient's adrenals of a humoral agent in donor blood. The rate of corticosterone secretion was slightly higher during cross-circulation in three of the five experiments and fell during the recovery period.
Variations in adrenal blood flow occurred and the low values for aldosterone secretion for the third determination during the cross-circulation period in Dogs 4, 5 and 6 were associated with low adrenal blood flows (Table I) changed or increased slightly during cross-circulation; in one instance ( Figure 3 ) the slight increase continued during recovery.
Circulation of blood from normal dogs into the isolated adrenals of normal recipient animals
To determine the effects of cross-circulation per se on adrenocortical function, eight studies were performed by circulation of blood from a normal animal into the isolated adrenals of a normal recipient. Aldosterone secretion remained unchanged or decreased in all but two dogs and the mean values for aldosterone secretion were unchanged (Table II) . During recovery, aldosterone production was slightly elevated in some instances. The variable response is probably attributable to factors producing variation in aldosterone secretion in the normal donors. Corticosterone output was increased slightly (four dogs) or unchanged (four dogs) during cross circulation (Table II, Figure 4 ) and decreased during recovery. Adrenal blood flow was not appreciably different during the control and cross-circulation periods but was slightly reduced during recovery. The slight decline in arterial pressure was similar to that observed during cross-circulation of blood from dogs with secondary hyperaldosteronism into normal isolated adrenals. Inferior vena caval pressure was unchanged during cross-circulation but was frequently slightly elevated during recovery. In one experiment (Figure 4) , the thoracic inferior vena cava was constricted in the normal donor after three determinations had been made during cross-circulation; a 100 per cent increase in aldosterone secretion resulted. The data for arterial and venous pressures and adrenal blood flow on this animal are presented in Table II and recipient animals was regulated by means of screw clamps on the interconnecting tubing in an attempt to maintain a constant arterial pressure. Since changes in blood volume could not be excluded, the definitive study was performed by cross-circulation of blood from dogs with thoracic caval constriction into the isolated adrenals of normal dogs. As a control on the effects of cross-circulation per se or for any event associated with this experimental design, blood from normal dogs was circulated through normal isolated adrenals. Arterial pressure fell slightly during cross-circulation in most experiments but the decline in pressure was essentially the same for both experimental (Table I ) and control (Table II) groups. The arterial pressure in the donor animals was the same as the recorded pressure of blood which perfused the isolated adrenals since the blood pressure in the isolated aorta was derived entirely from blood from the donor. Aldosterone secretion increased in every instance and the change was highly significant during cross-circulation of blood from hyperaldosteronemic donors into isolated adrenals, whereas crosscirculation of blood from normal animals produced no consistent alteration in aldosterone secretion and the mean control and mean experimental values were the same. The present study demonstrates, therefore, the existence of an aldosterone stimulating agent in blood of dogs with experimental secondary hyperaldosteronism and it is suggested that this humoral agent is a hormone. The data agree with the suggestion of Orti, Ralli, Laken and Dumm (10) that a humoral substance provides the stimulus to aldosterone production. Orti and associates reported evidence from studies of rats on a low Na diet that a substance in urine increased aldosterone excretion in feces.
In most of the present experiments, corticosterone secretion was measured to examine the possibility that the circulating hormone is ACTH.
Corticosterone rather than hydrocortisone was studied because of the similar polarity of corticosterone monoacetate and aldosterone diacetate during descending chromatography; these two steroids were separated with the same solvent system during the first chromatography. In the dog, the effects of ACTH on corticosterone and hydrocortisone release are very similar. Farrell, Rauschkolb and Royce ( 11 ) showed similar marked drops in corticosterone and hydrocortisone after hypophysectomy and an increase in both steroids after ACTH administration. This marked drop in corticosterone after hypophysectomy in the dog and the response to ACTH have been confirmed (Reference 12, and unpublished observations). Also, in an earlier report (5) , concurrent measurements of Porter-Silber reacting steroids and corticosterone in adrenal vein plasma showed similar directional changes in every instance. Available evidence indicates, therefore, that alterations in either corticosterone or hydrocortisone secretion may reflect changes in circulating ACTH in the dog.
Increased circulating ACTH alone does not appear to explain the observed increase in aldosterone output, Aldosterone secretion increased markedly in every instance during cross-circulation of blood from dogs with secondary hyperaldosteronism into isolated adrenal whereas corticosterone secretion increased slightly in 60 per cent of the experiments. During the present recovery observations, aldosterone secretion was at the control level or slightly elevated whereas corticosterone output declined further and in many instances this decline was associated with a decrease in adrenal blood flow. In one experiment ( Figure  4 ) in which blood from a normal dog was circulated through normal isolated adrenals, aldosterone secretion fell while corticosterone output increased; subsequent constriction of the thoracic inferior vena cava of the normal donor resulted in a 100 per cent increase in aldosterone production but corticosterone secretion was unchanged. Also, the alterations in corticosterone secretion were similar during cross-circulation of blood from normal dogs into isolated adrenals to the changes found during cross-circulation of blood from dogs with chronic caval constriction. During previous observations (5) , acute constriction of the thoracic inferior vena cava produced an increase in aldosterone secretion while corticosterone output fell.
Although these findings suggest different regulatory mechanisms for aldosterone and corticosterone secretion, the data do not exclude an influence of ACTH on aldosterone production. Both aldosterone and corticosterone output may have been increased during the control observations as a result of surgery. Hilton and associates (3) have reported near maximal output of hydrocortisone in the isolated adrenal preparation. Additional stud-ies are needed to identify this aldosterone stimulating substance and to determine its origin.
SUMMARY AND CONCLUSIONS
To test the possibility of a humoral mechanism in the regulation of aldosterone secretion, crosscirculation experiments were performed between dogs with thoracic inferior vena cava constriction and secondary hyperaldosteronism and normal recipient animals. Cross-circulation was established through the femoral vessels, or the isolated adrenals of normal animals were perfused with blood from a hyperaldosteronemic donor. Control and recovery periods were obtained with the recipient's blood or by cross-circulation of blood from a normal dog. Repeated determinations of aldosterone and corticosterone were made in adrenal vein plasma by the double isotope derivative method. Aldosterone secretion in the recipient or in the recipient's isolated adrenals increased markedly in nine of 10 experiments, and returned to the control level in the isolated adrenals of five dogs with recovery observations. Corticosterone secretion increased only slightly in four of eight experiments. No consistent alterations in the concentrations of plasma Na and K were detected. During crosscirculation of blood from eight normal dogs into the isolated adrenals of normal animals, aldosterone secretion was unchanged or decreased in all but two dogs; a slight increase in corticosterone secretion occurred in one-half of the animals. It is concluded that a humoral agent, possibly a hormone, stimulates the adrenals to secrete aldosterone in dogs with secondary hyperaldosteronism.
